Share

December 02, 2014; 83 (23) ArticleOpen Access

Improving functional disability and cognition in Parkinson disease

Randomized controlled trial

Javier Peña, Naroa Ibarretxe-Bilbao, Inés García-Gorostiaga, Maria Angeles Gomez-Beldarrain, María Díez-Cirarda, Natalia Ojeda
First published October 31, 2014, DOI: https://doi.org/10.1212/WNL.0000000000001043
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
3130

Share

Article Information

vol. 83 no. 23 2167-2174
DOI: 
https://doi.org/10.1212/WNL.0000000000001043
PubMed: 
25361785
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received November 7, 2013
  • Accepted in final form August 29, 2014
  • First Published October 31, 2014.

Article Versions

Copyright & Usage: 
© 2014 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-Noncommercial No Derivative 3.0 License, which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.

Author Disclosures

    1. Javier Peña, PhD,
    2. Naroa Ibarretxe-Bilbao, PhD,
    3. Inés García-Gorostiaga, MD,
    4. Maria Angeles Gomez-Beldarrain, PhD,
    5. María Díez-Cirarda, MSc and
    6. Natalia Ojeda, PhD
  1. Javier Peña, PhD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) Department of Education and Science of the Basque Government (Equipo A).Investigator. 2012-16. (2) Department of Health of the Basque Government, grant number: 2011111117. Investigator. 2012-14. (3) Spanish Ministry of Economy and Competitiveness. grant number: PSI2012-32441. Investigator. 2012-14.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Naroa Ibarretxe-Bilbao, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Project title: Correlatos neuroanat�micos y neurofuncionales de los diferentes subtipos de deterioro cognitivo leve en la enfermedad de Parkinson Funding source: Departamento de Sanidad del Gobierno Vasco Grant number: 2011111117 Project title: Cambios cerebrales estructurales y funcionales asociados a la rehabilitaci�n cognitiva en enfermedades neurodegenerativas Funding source: Ministerio de Econom�a y Competitividad Grant number: PSI2012-32441

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Inés García-Gorostiaga, MD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Maria Angeles Gomez-Beldarrain, PhD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. María Díez-Cirarda, MSc and
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Natalia Ojeda, PhD
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1.Funding source: Basque Gov, Dpt of Health. Grant number:2011111102, role: PI, yrs: 2012-2014 2.-FUnding source: Basque Gv, Dpt of Health Sanidad del Gobierno Vasco. Grant number: 2011111117, role: co-investigator; yrs: 2012-2015 3.Funding Source: Spanish Ministry of Economy and Competitiveness. Grant number: PSI2012-32441. yrs: 2012- 2015. Rol: Co-investigator

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Methods and Experimental Psychology (J.P., N.I.-B., M.D.-C., N.O.), Faculty of Psychology and Education, University of Deusto, Bilbao, Basque Country; and Department of Neurology (I.G.-G., M.A.G.-B.), Galdakao Hospital, Basque Country, Spain.
  1. Correspondence to Dr. Ibarretxe-Bilbao: naroa.ibarretxe{at}deusto.es
View Full Text

Article usage

Article usage: October 2014 to March 2021

AbstractFullPdfSource
Oct 20142103Highwire
Nov 201410540313Highwire
Dec 20141904117264Highwire
Jan 2015438174134Highwire
Jan 201503417pmc
Feb 20151812474Highwire
Feb 201503922pmc
Mar 20151304145Highwire
Mar 2015012553pmc
Apr 2015937043Highwire
Apr 2015011848pmc
May 2015703442Highwire
May 2015010961pmc
Jun 2015672336Highwire
Jun 201507035pmc
Jul 2015732945Highwire
Jul 201503320pmc
Aug 2015572925Highwire
Aug 201503716pmc
Sep 2015563427Highwire
Sep 201506831pmc
Oct 2015713435Highwire
Oct 201506024pmc
Nov 2015703934Highwire
Nov 201504926pmc
Dec 2015532420Highwire
Dec 201504418pmc
Jan 2016553619Highwire
Jan 201604423pmc
Feb 2016502714Highwire
Feb 201603433pmc
Mar 2016502527Highwire
Mar 201604023pmc
Apr 2016292023Highwire
Apr 201603725pmc
May 2016531216Highwire
May 201602716pmc
Jun 2016473122Highwire
Jun 201603414pmc
Jul 2016373230Highwire
Jul 20160358pmc
Aug 2016302910Highwire
Aug 20160189pmc
Sep 2016492428Highwire
Sep 201604518pmc
Oct 2016572926Highwire
Oct 201606313pmc
Nov 2016812149Highwire
Nov 201603510pmc
Dec 201641174Highwire
Dec 201602911pmc
Jan 2017341419Highwire
Jan 201703414pmc
Feb 2017292115Highwire
Feb 201703918pmc
Mar 2017341619Highwire
Mar 201703317pmc
Apr 2017201612Highwire
Apr 201762936pmc
May 201730225Highwire
May 201722324pmc
Jun 2017191317Highwire
Jun 201761716pmc
Jul 2017271915Highwire
Jul 201781820pmc
Aug 201711107Highwire
Aug 201771413pmc
Sep 201718810Highwire
Sep 201772422pmc
Oct 2017251016Highwire
Oct 2017132931pmc
Nov 2017251512Highwire
Nov 2017152426pmc
Dec 201722239Highwire
Jan 2018162220Highwire
Feb 201818197Highwire
Mar 2018213421Highwire
Apr 2018113015Highwire
Apr 201841111pmc
May 2018223120Highwire
Jun 2018103915Highwire
Jun 201831821pmc
Jul 201816259Highwire
Aug 201875513Highwire
Aug 201873135pmc
Sep 2018113712Highwire
Oct 2018223415Highwire
Nov 2018238716Highwire
Dec 201814756Highwire
Jan 2019129632Highwire
Feb 2019175115Highwire
Mar 2019233317Highwire
Apr 2019173415Highwire
May 2019112812Highwire
Jun 201914327Highwire
Jul 2019133514Highwire
Aug 2019103013Highwire
Sep 2019123923Highwire
Oct 2019132513Highwire
Nov 2019363914Highwire
Dec 2019144014Highwire
Jan 2020226218Highwire
Feb 2020142314Highwire
Mar 2020213120Highwire
Apr 2020251116Highwire
May 2020201634Highwire
Jun 2020152514Highwire
Jul 202023321Highwire
Aug 2020101712Highwire
Sep 202025269Highwire
Oct 2020175731Highwire
Nov 2020214333Highwire
Dec 2020334018Highwire
Jan 2021243946Highwire
Feb 2021236621Highwire
Mar 2021286123Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me